<- Go Home
Aspira Women's Health Inc.
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.
Market Cap
$14.2M
Volume
54.7K
Cash and Equivalents
$962.0K
EBITDA
-$17.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$5.2M
Profit Margin
57.84%
52 Week High
$5.65
52 Week Low
$0.74
Dividend
N/A
Price / Book Value
-3.06
Price / Earnings
-0.62
Price / Tangible Book Value
-3.06
Enterprise Value
$15.6M
Enterprise Value / EBITDA
-0.93
Operating Income
-$17.4M
Return on Equity
753.08%
Return on Assets
-185.71
Cash and Short Term Investments
$962.0K
Debt
$2.4M
Equity
-$3.7M
Revenue
$8.9M
Unlevered FCF
-$8.9M
Sector
Health Care Equipment and Supplies
Category
N/A